Data as of Oct 23
| +0.19 / +6.33%|
Cellceutix Corp. is a clinical stage biotechnology company, which focuses on discovering small molecule drugs for hard to treat diseases, including drug-resistant cancers, psoriasis, autism and inflammatory disease. It flagship compound, Kevetrin, is an anti-cancer drug which has demonstrated the ability in pre-clinical studies to regulate the p53 pathway and attack cancers. The company was founded by Krishna Kumar Menon and Leo Ehrlich in June 2007 and is headquartered in Beverly, MA.
|Leo Ehrlich||Chairman, CEO, CFO, Secretary, Director & CAO|
|Krishna Kumar Menon||President, Director & Chief Scientific Officer|